A MEQ-deleted marek's disease virus cloned as a bacterial artificial chromosome is a highly efficacious vaccine

Avian Diseases

Volumn 54, Issue 2, 2010, Pages 862-869

  Silva, Robert F ^a   Dunn, John R ^a   Cheng, Hans H ^a   Niikura, Masahiro ^a,b  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

^b SIMON FRASER UNIVERSITY   (Canada)

Author keywords

BAC; Herpesvirus; MDV; MEQ; Oncogene; Poultry; Vaccine

Indexed keywords

ECO Q PROTEIN, GALLID HERPESVIRUS 2; ECO-Q PROTEIN, GALLID HERPESVIRUS 2; ONCOPROTEIN; VIRUS VACCINE;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CHICKEN; CLASSIFICATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GENE DELETION; GENETICS; IMMUNOLOGY; MARDIVIRUS; MAREK DISEASE; MOLECULAR CLONING; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOGENICITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIROLOGY; VIRULENCE; VIRUS GENOME;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CHICKENS; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CLONING, MOLECULAR; GENE DELETION; GENOME, VIRAL; MARDIVIRUS; MAREK DISEASE; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, VIRAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VIRAL VACCINES; VIRULENCE;

BACTERIA (MICROORGANISMS); GALLID HERPESVIRUS 2; GALLUS GALLUS; HERPESVIRIDAE;

EID: 77953846564     PISSN: 00052086     EISSN: None     Source Type: Journal    
DOI: 10.1637/9048-090409-Reg.1     Document Type: Article

References (32)

1. Bacon, L. D., H. D. Hunt, and H. H. Cheng. A review of the development of chicken lines to resolve genes determining resistance to diseases. Poult. Sci. 79:1082-1093. 2000.
2. Bülow, V. V., and P. M. Biggs. Differentiation between strains of Marek's disease virus and turkey herpesvirus by immunofluorescence assays. Avian Pathol. 4:133-146. 1975.
3. Churchill, A. E., R. C. Chubb, and W. Baxendale. The attenuation with loss of oncogenicity of the herpes-type virus of Marek's disease (strain HPRS-16) on passage in cell culture. J. Gen. Virol. 4:557-564. 1969.
4. Cui, H. Y., Y. F. Wang, X. M. Shi, T. Q. An, G. Z. Tong, D. S. Lan, L. He, C. J. Liu, and M. Wang. Construction of an infectious Marek's disease virus bacterial artificial chromosome and characterization of protection induced in chickens. J. Virol. Methods 156:66-77. 2009.
5. Darteil, R., M. Bublot, E. Laplace, J.-F. Bouquet, J.-C. Audonnet, and M. Riviere. Herpesvirus of turkey recombinant viruses expressing infectious bursal disease virus (IBDV) VP2 immunogen induce protection against an IBDV virulent challenge in chickens. Virology 211:481-490. 1995.
6. Ferrin, L. J., and R. D. Camerini-Otero. Selective cleavage of human DNA: RecA-assisted restriction endonuclease (RARE) cleavage. Science 254:1494-1497. 1991.
7. Gimble, F. S., and J. Wang. Substrate recognition and induced DNA distortion by the PI-SceI endonuclease, an enzyme generated by protein splicing. J. Mol. Biol. 263:163-180. 1996.
8. Gimeno, I. M., and R. F. Silva. Deletion of the Marek's disease virus UL41 gene (vhs) has no measurable effect on latency or pathogenesis. Virus Genes 36:499-507. 2008.
9. Lee, E. C., D. Yu, J. Martinez De Velasco, L. Tessarollo, D. A. Swing, D. L. Court, N. A. Jenkins, and N. G. Copeland. A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics 73:56-65. 2001.
10. Lee, L. E., R. L. Witter, S. M. Reddy, P. Wu, N. Yanagida, and S. Yoshida. Protection and synergism by recombinant fowl pox vaccines expressing multiple genes from Marek's disease virus. Avian Dis. 47:549-558. 2003.
11. Lee, L. F., B. Lupiani, R. F. Silva, H. J. Kung, and S. M. Reddy. Recombinant Marek's disease virus (MDV) lacking meq oncogene confers protection against challenge with the very virulent plus strains of MDV. Vaccine 26:1887-1892. 2008.
12. Lupiani, B., L. F. Lee, X. Cui, I. Gimeno, A. Anderson, R. W. Morgan, R. F. Silva, R. L. Witter, H.-J. Kung, and S. M. Reddy. Marek's disease virus-encoded Meq gene is involved in transformation of lymphocytes but is dispensable for replication. Proc. Natl. Acad. Sci. U. S. A. 101:11815-11820. 2004. (Pubitemid 39095377)
13. Morgan, R. W., J. Gelb Jr., C. R. Pope, and P. J. A. Sondermeijer. Efficacy in chickens of a herpesvirus of turkeys recombinant vaccine containing the fusion gene of Newcastle disease virus: onset of production and effect of maternal antibodies. Avian Dis. 37:1032-1040. 1993.
14. Nazerian, K., L. F. Lee, N. Yanagida, and R. Ogawa. Protection against Marek's disease by a fowlpox virus recombinant expressing the glycoprotein B of Marek's disease virus. J. Virol. 66:1409-1413. 1992.
15. Niikura, M., J. Dodgson, and H. Cheng. Direct evidence of host genome acquisition by the alphaherpesvirus Marek's disease virus. Arch. Virol. 151:537-549. 2006.
16. Niikura, M., J. Dodgson, R. F. Silva, and H. Cheng. Infectious bacterial artificial chromosome clones of Marek's disease virus possessing the complete genome derived from Md5 cosmid clones. In: 4th International Workshop on the Molecular Pathogenesis of Marek's Disease Virus. M. Parcells, R. Morgan, J. Burnside, C. J. Schmidt, E. L. Bernberg, C. Kinney, and E. Eppler, eds. University of Delaware, Newark. p. 37, 2006.
17. Okazaki, W., H. G. Purchase, and B. R. Burmester. Protection against Marek's disease by vaccination with a herpesvirus of turkeys. Avian Dis. 14:413-429. 1970.
18. Petherbridge, L., A. C. Brown, S. J. Baigent, K. Howes, M. A. Sacco, N. Osterrieder, and V. K. Nair. Oncogenicity of birulent Marek's disease virus cloned as bacterial artificial chromosomes. J. Virol. 78:13376-13380. 2004.
19. Reddy, S. K., J. M. Sharma, J. Ahmad, D. N. Reddy, J. K. McMillen, S. M. Cook, M. A. Wild, and R. D. Schwartz. Protective efficacy of a recombinant herpesvirus of turkeys as an in ovo vaccine against Newcastle and Marek's diseases in specific-pathogen-free chickens. Vaccine 14:469-477. 1996.
20. Reddy, S. M., B. Lupiani, I. M. Gimeno, R. F. Silva, L. F. Lee, and R. L. Witter. Rescue of a pathogenic Marek's disease virus with overlapping cosmid DNAs: use of a pp38 mutant to validate the technology for the study of gene function. Proc. Natl. Acad. Sci. U. S. A. 99:7054-7059. 2002.
21. Rispens, B. H., H. Van Vloten, N. Mastenbroek, H. J. L. Maas, and K. A. Schat. Control of Marek's disease in the Netherlands. I. Isolation of an avirulent Marek's disease virus (strain CVI 988) and its use in laboratory vaccination trials. Avian Dis. 16:108-125. 1972.
22. Rispens, B. H., H. Van Vloten, N. Mastenbroek, H. J. L. Maas, and K. A. Schat. Control of Marek's disease in the Netherlands. II. Field trials on vaccination with an avirulent strain (CVI 988) of Marek's disease virus. Avian Dis. 16:126-138. 1972.
23. Ross, L. J. N., M. M. Binns, P. Tyers, J. Pastorek, V. Zelnik, and S. Scott. Construction and properties of a turkey herpesvirus recombinant expressing the Marek's disease virus homologue of glycoprotein B of herpes simplex virus. J. Gen. Virol. 74:371-377. 1993. (Pubitemid 23092889)
24. Ross, N., G. O'Sullivan, and F. Coudert. Influence of chicken genotype on protection against Marek's disease by a herpesvirus of turkeys recombinant expressing the glycoprotein B (gB) of Marek's disease virus. Vaccine 14:187-189. 1996.
25. Saif, Y. M., A. M. Fadly, J. R. Glisson, L. R. McDougald, L. K. Nolan, and D. E. Swayne. Diseases of poultry, 12th ed. Blackwell Publishing Professional, Ames, IA. 2008.
26. Schumacher, D., B. K. Tischer, W. Fuchs, and N. Osterrieder. Reconstitution of Marek's disease virus serotype 1 (MDV-1) from DNA cloned as a bacterial artificial chromosome and characterization of a glycoprotein B-negative MDV-1 mutant. J. Virol. 74:11088-11098. 2000.
27. Sharma, J. M., and C. K. Graham. Influence of maternal antibody on efficacy of embryo vaccination with cell-associated and cell-free Marek's disease vaccine. Avian Dis. 26:860-870. 1982.
28. Tischer, B. K., J. Von Einem, B. Kaufer, and N. Osterrieder. Twostep red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli. BioTechniques 40:191-197. 2006.
29. Witter, R. L. Evolution of virulence of Marek's disease virus: evidence for a novel pathotype. In: Current research on Marek's disease. R. F. Silva, H. H. Cheng, P. M. Coussens, L. F. Lee, and L. F. Velicer, eds. American Association of Avian Pathologists, Kennett Square, PA. pp. 86-91. 1996.
30. Witter, R. L. Increased virulence of Marek's disease virus field isolates. Avian Dis. 41:149-163. 1997.
31. Witter, R. L., B. W. Calnek, C. Buscaglia, I. M. Gimeno, and K. A. Schat. Classification of Marek's disease viruses according to pathotype: philosophy and methodology. Avian Pathol. 34:75-90. 2005.
32. Witter, R. L., J. M. Sharma, and A. M. Fadly. Pathogenicity of variant Marek's disease virus isolates in vaccinated and unvaccinated chickens. Avian Dis. 24:210-232. 1980.